Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
total_cholesterol [2025/01/28 04:31] – removed admin | total_cholesterol [2025/01/28 05:01] (current) – admin | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | |[[clinical_biochemistry_section|Home]]|[[clinical_biochemistry|]]|[[examination_procedures|]]| | ||
+ | |||
+ | Total Cholesterol Examination Procedure | ||
+ | **1.Purpose of Examination: | ||
+ | To lay down standard operating procedure for serum Total Cholesterol estimation by CHOD-PAP Method in Biochemistry section of LSSTH, Bhavnagar. | ||
+ | |||
+ | **2.Principle of the procedure used for examinations: | ||
+ | The Cholesterol2 assay is an automated clinical chemistry assay. Cholesterol esters are enzymatically hydrolyzed by cholesterol esterase to cholesterol and free fatty acids. Free cholesterol, | ||
+ | (quinoneimine dye) which is quantitated at 604 nm. | ||
+ | |||
+ | **3.Performance: | ||
+ | Linearity: upto 705mg/dl | ||
+ | Limit of Detection (LOD):Serum : 5.0 mg/dl | ||
+ | Limit of Quantitation (LOQ),: | ||
+ | The LOQ is the analyte concentration at which the CV = 20%. | ||
+ | |||
+ | **4.Type of Primary Sample:** | ||
+ | Serum or Plasma [[sample_collection_manual|]] | ||
+ | |||
+ | **5.Patient Preparation: | ||
+ | Instruction should be given to the patient | ||
+ | Verbal consent of patient should be taken before collecting blood sample. | ||
+ | Patient should relax for about 5 minutes before the venepuncture.. | ||
+ | |||
+ | **6.Type of Container and additives :** | ||
+ | Plain Vaccutainer with no additives | ||
+ | |||
+ | **7.Required Equipment and reagents:** | ||
+ | Centrifuge, Auto-Pipette, | ||
+ | |||
+ | **8.Enviromental & Safety control:** | ||
+ | Reagent R1 contains sodium azide. contact with acids liberates very toxic gas | ||
+ | |||
+ | **9.Precautions: | ||
+ | Wear protective gloves / protective clothing / eye protection | ||
+ | Do not breathe mist / vapors / spray | ||
+ | Wash hands thoroughly after handling | ||
+ | Keep only in original container | ||
+ | |||
+ | **10.Calibration Procedure: | ||
+ | Give Calibration with Consolidated Chemistry | ||
+ | **Manual calibration is done on following circumstances: | ||
+ | * After instrument repair | ||
+ | * After new reagent lot | ||
+ | * QC data not satisfactory - QC outlier | ||
+ | Note: Verify calibration with at least two levels of controls according to the established quality control requirements for your laboratory. If control results fall outside acceptable ranges, recalibration may be necessary | ||
+ | |||
+ | **11.Procedural Steps:** | ||
+ | * Verify that all necessary reagents present | ||
+ | * Take100µl Sample. | ||
+ | * Put on sample loader ,select & Order Test | ||
+ | * Press run. | ||
+ | |||
+ | **12.Quality Control Procedure: | ||
+ | The Laboratory runs Lypocheck Assayed Chemistry Control level 1 & level 2 Once a day. Monthly L-J charts are reviewed & for any QC outlier root cause analysis are done & corrective actions are taken according to the error. | ||
+ | The Laboratory Participates in EQAS programme EQAS report is reviewed and if any result go outlier, then root cause analysis is done & corrective actions are taken according to the error. | ||
+ | |||
+ | **13.Interferences & Cross-Reactions: | ||
+ | InterferingSubstance | ||
+ | * No interference from Bilirubin up to7.5 mg/dL | ||
+ | * No interference from Hemoglobin up to750 mg/dL | ||
+ | * No interference from Intralipid up to 1000 mg/dl | ||
+ | * No interference from Ascorbate up to 1.5 mg/dl | ||
+ | |||
+ | **14.Principle of Procedure for Calculating Results including where relevant, the measurement uncertainty of measured quantity values:** | ||
+ | Instrument measures the absorbance of a calibrator of known concentration. This point determines the slope of a straight line that relates absorbance to concentration. Instrument calculates a constant which is the inverse of the slope of the straight line. | ||
+ | Sample Concentration: | ||
+ | Cs = Sample Concentration | ||
+ | K = Constant | ||
+ | As = Sample Absorbance | ||
+ | Measurement uncertainty: | ||
+ | Highest CV% of last 6 months | ||
+ | Refer Annexure I | ||
+ | |||
+ | **15.Biological Reference Interval:** | ||
+ | Adult : < | ||
+ | |||
+ | **16.Reportable interval of patient examination results:** | ||
+ | Up to 500mg/dl | ||
+ | |||
+ | * Instruction for determining Quantitative results when a results is not within the measurement | ||
+ | * Serum and plasma specimens with Cholesterol values exceeding the 705mg/dl, dilution need by following the Manual Dilution Procedure, or the Automatic Dilution Protocol provided in the assay parameters | ||
+ | * Automated Dilution Protocol | ||
+ | * When using the Automated Dilution Protocol, the system performs a dilution of the specimen and automatically corrects the concentration by multiplying the result by the appropriate dilution factor. | ||
+ | |||
+ | **17.Manual Dilution Procedure: | ||
+ | * Dilute the specimen with saline (0.85% to 0.90% NaCl). | ||
+ | * Enter the dilution factor in the Patient or Control order screen | ||
+ | |||
+ | **18.Stability of sample** | ||
+ | Serum or plasma-At Room temperature18°–28°C (64°–82°F) stability ≤ 24 hours | ||
+ | |||
+ | **19.Storage of sample** | ||
+ | 2-8° C for 1 days (Retention period for re-examination and/or additional tests is 24 hrs.) | ||
+ | |||
+ | **20.Reagent Storage and stability** | ||
+ | Reagent is stored at 2-8 °c.Reagent stability is 30 days if the reagent is uncapped and on board. | ||
+ | |||
+ | **21.Turn around time (TAT)** | ||
+ | 6.0 hours after collection, | ||
+ | |||
+ | **22.Critical Value:**NA | ||
+ | |||
+ | **23.Laboratory Interpretation: | ||
+ | The common causes of high cholesterol level are as follows : | ||
+ | |||
+ | **24.Potential source of variation: | ||
+ | - Expiry of Kit | ||
+ | - Instrumental Error | ||
+ | - Presence of interfering source | ||
+ | - Instrumental Error | ||
+ | - Reagent contamination | ||
+ | - Storage condition not proper | ||
+ | |||
+ | **25.Reagent Handling** | ||
+ | Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to sit at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles | ||
+ | |||
+ | **26.REFERENCE: | ||
+ | - US department of labor, | ||
+ | - US department of health and human services. Biosafety in MIcrobiological and biomedical laboratories. | ||
+ | - World health organization. Biosafety manual,3rd edition. | ||
+ | - World health organization. Biosafety manual,3rd edition. | ||
+ | - Clinical and laboratory std institute . Protection of Laboratory workers from oocupationally acquired infection; Approved guideline -4th edition. | ||
+ | - Burtis CA,Ashwood ER, | ||
+ | - ARCHITECT | ||
+ | - NABL 112 effective from 01/06/2019 | ||
+ | |||
+ | |**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| | ||
+ | |||
+ | ^ Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH), | ||
+ | ^Document No.1^**Document Name**: Total Cholesterol Examination Procedure^**Unique ID**:LSSTH /BIOCHEM/ SOP-5^^ | ||
+ | ^Issue No. : 01^Issue Date : | ||
+ | ^Amend No.^ Amend Date ^Prepared by: Section Incharge^Approved & Issued by: HOD, | ||